1. The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria

   • Andrea Lanese
   • Enrico Franceschi
   • Alba A. Brandes

   Commentary Open access 16 July 2018 Pages: 105 - 108

2. The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice

   • Adi Litmanovich
   • Khaled Khazim
   • Idan Cohen

   Review Open access 28 November 2018 Pages: 109 - 127

   

3. Mastocytosis: One Word for Different Diseases

   • Marianna Criscuolo
   • Luana Fianchi
   • Livio Pagano

   Review Open access 29 October 2018 Pages: 129 - 140

   

4. Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation

   • Simon J. Johnston
   • Kwok-Leung Cheung

   Review Open access 10 July 2018 Pages: 141 - 156

   

5. Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases

   • Shunji Takahashi
   • Seigo Kinuya
   • Yoshiyuki Kakehi

   Original Research Open access 11 December 2018 Pages: 157 - 171

   

6. Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient–Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study

   • Philip Cornford
   • Kieran Jefferson
   • John Gilbody

   Original Research Open access 05 November 2018 Pages: 173 - 187

   

7. Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

   • Tian Qi Wang
   • Joseph N. Samuel
   • Doris Howell

   Original Research Open access 22 October 2018 Pages: 189 - 201

   

8. Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

   • Takashi Seto
   • Naoyuki Nogami
   • Hideo Saka

   Original Research Open access 28 August 2018 Pages: 203 - 215